复星医药 (600196.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(复星医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 46.0045.0049.0051.0049.0048.0048.0044.00
 单季度销售净利率(%) 2.007.009.0010.009.009.0011.006.00
 单季度净资产收益率ROE(%) -1.002.002.003.002.003.001.00
 单季度总资产净利率ROA(%) -1.001.001.001.001.001.001.00
单季度财务摘要:
 单季度营业总收入(元) 10,699,420,532.009,304,926,476.0010,524,471,741.0010,870,720,839.0012,341,475,592.0010,270,017,625.0010,958,114,272.0010,381,939,406.00
 单季度营业总成本(元) 10,999,797,744.009,652,237,259.0010,533,757,495.0010,098,284,416.0011,947,283,522.009,796,122,037.009,923,830,336.009,679,028,542.00
 单季度营业收入(元) 10,699,420,532.009,304,926,476.0010,524,471,741.0010,870,720,839.0012,341,475,592.0010,270,017,625.0010,958,114,272.0010,381,939,406.00
 单季度营业利润(元) -34,689,866.00659,587,014.001,255,471,465.001,427,139,292.001,064,123,569.001,045,793,087.001,650,793,063.00895,946,663.00
 单季度利润总额(元) -27,888,611.00636,986,518.001,270,705,939.001,384,764,032.001,171,537,577.001,030,433,502.001,484,763,455.00887,647,050.00
 单季度净利润(元) 241,253,890.00608,584,258.00930,971,168.001,114,254,110.001,156,159,818.00927,979,255.001,219,039,739.00644,285,309.00
 单季度归属母公司股东的净利润(元) 103,199,883.00505,594,061.00790,500,207.00986,971,662.001,276,437,578.00907,033,448.001,084,821,336.00462,512,221.00
 单季度经营活动产生的现金流量(元) 952,576,577.00651,632,352.00936,764,098.00873,244,036.001,043,867,951.001,353,331,940.00954,776,561.00865,594,441.00
 单季度投资活动产生的现金流量(元) -534,997,342.00-922,266,619.00-2,224,851,022.00-137,175,389.00138,373,122.00-1,717,256,520.00-1,015,427,130.00-1,469,727,634.00
 单季度筹资活动产生的现金流量(元) -939,670,194.00-1,796,488,977.001,117,938,218.00281,971,154.00-514,654,359.002,522,944,634.00876,615,212.001,543,569,247.00
 单季度现金及现金等价物净增加(元) -579,773,903.00-1,977,210,082.00-61,368,471.00950,674,373.00476,611,399.002,410,261,401.00931,046,985.00892,430,139.00

前瞻产业研究院